Lilly Endowment giving IU medical school $25M to fund life sciences initiatives
The grant from the Indianapolis-based philanthropic giant is aimed at bolstering Indiana’s stature as a life sciences research hub.
Life Science & Biotech
Articles
16 Tech innovation district gears up for work under new CEO
The 16 Tech innovation district, an ambitious economic development project in the works in Indianapolis for more than a decade, has hired a top executive whose goal is to turn the downtrodden area into a thriving center for entrepreneurship and innovation.
IU Health, competitors turn focus to improving experience for patients, families
Around Indiana, hospitals are doubling down on the lofty goal of patient satisfaction. Some, like IU Health, are hiring managers to oversee various aspects of the patient experience, from registration to discharge.
Danville firm grows as other states embrace controversial chemical cremation method
Bio-Response Solution’s flagship product liquefies human corpses, turning muscle, flesh and fat into a coffee-colored effluent that can be swirled down the drain.
State using big data to attack opioid epidemic
Indiana’s Management Performance Hub is organizing and analyzing data to help state agencies make better decisions about fighting the opioid scourge and other systemic problems.
Brown calls genomics startup ‘riskiest thing I’ve ever done’
LifeOmic is seeking to help doctors provide more precise treatments for patients by sequencing their DNA.
Lilly hires ‘powerhouse’ D.C. lobbyist
Leigh Ann Pusey will join Eli Lilly and Co. next month as senior vice president for corporate affairs and communications.
Carmel biotech firm lands $8M in venture capital, grant funds
Founded in 2006, Fast BioMedical Inc. plans to use the money to help advance clinical trials and hire additional workers. It develops technologies to measure blood volume and kidney function.
Life sciences firms see some fundraising success but need massive sums
Around Indiana, life sciences companies are searching high and low for venture capital to fund promising but expensive new products, which can take a decade or longer to develop.
Local life sciences, pharma consultancy acquired by German firm
Safis Solutions LLC, a 15-year-old Indianapolis consulting firm that helps life science companies move their products through the government regulatory process, has been acquired by PharmaLex, the companies announced Monday.
How Dow won fight to save key product
When Dow AgroSciences needed to battle a proposed federal ban on one of its most important products, it drafted an army—its farmers.
FDA issues warning to local doctor for breaking protocol on drug trial
The federal agency says the Indianapolis doctor studying Pfizer’s Chantix last year failed to keep accurate records and used patients who didn’t meet the trial requirements.
Medical device software firm plans to add 120 employees
Indianapolis-based software company Greenlight.guru has moved operations from one downtown facility to another to accommodate expansion.
FOCUS: Biosciences institute’s chief scientific officer aims to foster commercialization
Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.
Startup that helps doctors direct-bill patients plans to add 64 workers
Freedom Healthworks, which expects to serve 12 physician practices with 6,000 patients by the end of the year, is relocating from Nora to downtown and tripling its office space.
High-tech compression garment maker lands FDA clearance
Fishers-based Recovery Force LLC took a big step this month toward its goal of bringing to market a wrap that’s designed to improve blood flow and enhance recovery for people battling serious health issues.
Purdue-based firm could change radiation treatments
Purdue University Professor You-Yeon Won’s development, called radio-luminescent nanoparticles, is designed to enhance the cancer-cell-killing effects of radiation treatment.
Holcomb calls to use $500M fund from Toll Road lease to fund entrepreneurship
Gov.-elect Eric Holcomb, who announced his legislative agenda Thursday, has roughly the same idea as Gov. Mike Pence when it comes to investing in early-stage Indiana companies, but wants to pay for the plan through a different fund.
Lilly trims profit guidance but says growth strategy on track
The company’s announcement reassured investors in the wake of last month’s news that the Alzheimer’s drug solanezumab had failed to demonstrate effectiveness during a large-scale clinical trial.
At Eli Lilly, tears, heartbreak and renewed determination
Eli Lilly and Co. employees knew the Alzheimer's treatment solanezumab was not a sure bet. But that didn’t make the pain any less acute after the company announced the drug had failed to demonstrate effectiveness during a 2,100-patient Phase 3 clinical trial.